Alimera Net Cash Flow Investment Acquisitions and Disposals from 2010 to 2024

ALIM Stock  USD 3.97  0.07  1.79%   
Check Alimera Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Alimera main balance sheet or income statement drivers, such as Depreciation And Amortization of 9.2 M, Interest Expense of 10.7 M or Selling General Administrative of 11.1 M, as well as many exotic indicators such as Price To Sales Ratio of 1.3, Dividend Yield of 0.0125 or Operating Cycle of 335. Alimera financial statements analysis is a perfect complement when working with Alimera Sciences Valuation or Volatility modules.
  
This module can also supplement Alimera Sciences' financial leverage analysis and stock options assessment as well as various Alimera Sciences Technical models . Check out the analysis of Alimera Sciences Correlation against competitors.
To learn how to invest in Alimera Stock, please use our How to Invest in Alimera Sciences guide.

About Alimera Sciences Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Alimera Sciences income statement, its balance sheet, and the statement of cash flows. Alimera Sciences investors use historical funamental indicators, such as Alimera Sciences's Net Cash Flow Investment Acquisitions and Disposals, to determine how well the company is positioned to perform in the future. Although Alimera Sciences investors may use each financial statement separately, they are all related. The changes in Alimera Sciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Alimera Sciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Alimera Sciences Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Alimera Sciences. Please read more on our technical analysis and fundamental analysis pages.
Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals in the United States and internationally. The company was incorporated in 2003 and is headquartered in Alpharetta, Georgia. Alimera Sciences operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 145 people.

Pair Trading with Alimera Sciences

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Alimera Sciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alimera Sciences will appreciate offsetting losses from the drop in the long position's value.

Moving against Alimera Stock

  0.63URGN UroGen Pharma Financial Report 9th of May 2024 PairCorr
  0.47MMSI Merit Medical Systems Financial Report 24th of April 2024 PairCorr
  0.46MRK Merck Company Fiscal Quarter End 31st of March 2024 PairCorr
The ability to find closely correlated positions to Alimera Sciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Alimera Sciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Alimera Sciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Alimera Sciences to buy it.
The correlation of Alimera Sciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alimera Sciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alimera Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Alimera Sciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Alimera Sciences is a strong investment it is important to analyze Alimera Sciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Alimera Sciences' future performance. For an informed investment choice regarding Alimera Stock, refer to the following important reports:
Check out the analysis of Alimera Sciences Correlation against competitors.
To learn how to invest in Alimera Stock, please use our How to Invest in Alimera Sciences guide.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Complementary Tools for Alimera Stock analysis

When running Alimera Sciences' price analysis, check to measure Alimera Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alimera Sciences is operating at the current time. Most of Alimera Sciences' value examination focuses on studying past and present price action to predict the probability of Alimera Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alimera Sciences' price. Additionally, you may evaluate how the addition of Alimera Sciences to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Is Alimera Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alimera Sciences. If investors know Alimera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alimera Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.84)
Revenue Per Share
3.159
Quarterly Revenue Growth
0.875
Return On Assets
(0.01)
Return On Equity
(1.59)
The market value of Alimera Sciences is measured differently than its book value, which is the value of Alimera that is recorded on the company's balance sheet. Investors also form their own opinion of Alimera Sciences' value that differs from its market value or its book value, called intrinsic value, which is Alimera Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alimera Sciences' market value can be influenced by many factors that don't directly affect Alimera Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alimera Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Alimera Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alimera Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.